alpha-Synuclein Inhibition of Mitochondrial Protein Import
α-突触核蛋白抑制线粒体蛋白输入
基本信息
- 批准号:9044369
- 负责人:
- 金额:$ 36.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAutonomic DysfunctionBindingCardiolipinsCellsCognitiveComplexConsensus SequenceDefectDiseaseDopamineEnvironmental Risk FactorEtiologyGeneticGenomeGenus HippocampusImpairmentIndividualLipidsMaintenanceMeasuresMediatingMembraneMitochondriaMitochondrial ProteinsModificationN-terminalNatureNerve DegenerationNeurodegenerative DisordersNitratesOuter Mitochondrial MembraneParkinson DiseasePathogenesisPhosphorylationPoint MutationPost-Translational Protein ProcessingPower PlantsProductionProtein ImportProteinsRNA SplicingReactive Oxygen SpeciesRespirationSignal TransductionSignaling ProteinSolutionsSubstantia nigra structureSulfhydryl CompoundsSurveysSymptomsSynapsesSystemTherapeuticTimeVariantalpha synucleinbasecombatdopaminergic neurongenetic manipulationmitochondrial dysfunctionmotor impairmentmutantnitrationnoveloverexpressionoxidationoxidative damagepublic health relevancereceptorsmall hairpin RNAtranslocase
项目摘要
DESCRIPTION (provided by applicant): Parkinson disease (PD) is a common neurodegenerative disorder resulting in motor impairment, cognitive and psychiatric symptoms and autonomic dysfunction. Genetic and environmental factors have been implicated in PD pathogenesis, and it appears that mitochondrial defects and accumulation of the synaptic protein, α- synuclein, are common to most forms of the disease. Moreover, there is evidence of a bidirectional interaction between mitochondrial dysfunction and α-synuclein accumulation. Inhibition of mitochondrial complex I leads to accretion and oligomerization of α-synuclein, and increased levels of α-synuclein cause mitochondrial impairment and production of reactive oxygen species (ROS). The nature of the interaction between α- synuclein and mitochondria remains obscure, and it is unclear whether unmodified monomeric α-synuclein is responsible for these effects, or whether posttranslational modifications which have been implicated in pathogenesis, such as oligomerization, dopamine modification, phosphorylation or nitration are important. Mitochondria contain their own genome, but it encodes only 13 proteins, so they must import about 99% of the >1000 proteins they contain. Mitochondrial protein import occurs through complex and highly regulated systems, the best understood of which recognizes N-terminal mitochondrial targeting signals (MTS) on proteins destined for import. While there is no consensus sequence, MTS characteristically form an amphipathic helix that is recognized by a receptor protein, TOM20, which is a subunit of the translocase complex of the outer mitochondrial membrane (TOM). Although monomeric α-synuclein is an intrinsically disordered protein in solution, in association with anionic lipids in membranes, it forms an amphipathic helix
similar to known MTS motifs. In this context, we have strong evidence that certain forms of posttranslationally-modified α-synuclein bind specifically to TOM20 and interfere with import of mitochondrially-targeted proteins. We propose to study the interaction of α-synuclein with mitochondrial import machinery in the following aims: (1) Define the specific forms of α-synuclein that inhibit mitochondrial protein import; (2) Define key binding partners and binding parameters; (3) Determine functional consequences of α-synuclein-induced impairment of mitochondrial protein import; (4) Investigate whether blockade of mitochondrial protein import causes nigrostriatal neurodegeneration similar to α-synuclein overexpression; and (5) Examine the potential for genetic manipulation of mitochondrial import to protect against AAV2-mediated α-synuclein overexpression in substantia nigra.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J Timothy Greenamyre其他文献
Regulation of complex I by Engrailed is complex too
Engrailed 对复合物 I 的调节也很复杂
- DOI:
10.1038/nn.2939 - 发表时间:
2011-09-27 - 期刊:
- 影响因子:20.000
- 作者:
Laurie H Sanders;J Timothy Greenamyre - 通讯作者:
J Timothy Greenamyre
J Timothy Greenamyre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J Timothy Greenamyre', 18)}}的其他基金
LRRK2 and oxidative stress in Parkinson’s disease
LRRK2 与帕金森病的氧化应激
- 批准号:
10799999 - 财政年份:2023
- 资助金额:
$ 36.04万 - 项目类别:
Role of LRRK2 in idiopathic Parkinson's disease
LRRK2 在特发性帕金森病中的作用
- 批准号:
10224659 - 财政年份:2017
- 资助金额:
$ 36.04万 - 项目类别:
A slowly progressive, endogenous synucleinopathy model of Parkinson's disease
帕金森病的缓慢进展的内源性突触核蛋白病模型
- 批准号:
9211455 - 财政年份:2017
- 资助金额:
$ 36.04万 - 项目类别:
alpha-Synuclein Inhibition of Mitochondrial Protein Import
α-突触核蛋白抑制线粒体蛋白输入
- 批准号:
9279278 - 财政年份:2015
- 资助金额:
$ 36.04万 - 项目类别:
MtDNA damage as a biomarker for environmental mitochondrial toxicity
线粒体 DNA 损伤作为环境线粒体毒性的生物标志物
- 批准号:
8334581 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
MtDNA damage as a biomarker for environmental mitochondrial toxicity
线粒体 DNA 损伤作为环境线粒体毒性的生物标志物
- 批准号:
8623989 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I Inhibitors
DJ-1 在星形胶质细胞介导的针对复合物 I 抑制剂的神经保护中
- 批准号:
8841727 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
MtDNA damage as a biomarker for environmental mitochondrial toxicity
线粒体 DNA 损伤作为环境线粒体毒性的生物标志物
- 批准号:
8501468 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
MtDNA damage as a biomarker for environmental mitochondrial toxicity
线粒体 DNA 损伤作为环境线粒体毒性的生物标志物
- 批准号:
8216242 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
DJ-1 in Astrocyte-Mediated Neuroprotection Against Complex I Inhibitors
DJ-1 在星形胶质细胞介导的针对复合物 I 抑制剂的神经保护中
- 批准号:
8663700 - 财政年份:2011
- 资助金额:
$ 36.04万 - 项目类别:
相似海外基金
Impact of Autonomic Dysfunction on Multi-Organ Dysfunction following Severe TBI: The AUTO-BOOST Study
严重 TBI 后自主神经功能障碍对多器官功能障碍的影响:AUTO-BOOST 研究
- 批准号:
10607731 - 财政年份:2023
- 资助金额:
$ 36.04万 - 项目类别:
Autonomic Dysfunction in Patients with HFpEF
HFpEF 患者的自主神经功能障碍
- 批准号:
10587484 - 财政年份:2023
- 资助金额:
$ 36.04万 - 项目类别:
Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals with Spinal Cord Injuries
轻度间歇性缺氧:脊髓损伤患者自主神经功能障碍的预防措施
- 批准号:
10742912 - 财政年份:2022
- 资助金额:
$ 36.04万 - 项目类别:
Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals with Spinal Cord Injuries
轻度间歇性缺氧:脊髓损伤患者自主神经功能障碍的预防措施
- 批准号:
10537424 - 财政年份:2022
- 资助金额:
$ 36.04万 - 项目类别:
Muticentre Assessment of Cardiovascular Hemodynamics and Autonomic Dysfunction with Long COVID
长新冠肺炎期间心血管血流动力学和自主神经功能障碍的多中心评估
- 批准号:
448847 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:
Operating Grants
Investigating Autonomic Dysfunction as an Early Pathologic Feature of Huntington’s Disease
研究自主神经功能障碍作为亨廷顿病的早期病理特征
- 批准号:
10212681 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:
The Association of Autonomic Dysfunction with the Relationship between Depression and Coronary Disease
自主神经功能障碍与抑郁症和冠心病之间的关系
- 批准号:
10527469 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:
Investigating Autonomic Dysfunction as an Early Pathologic Feature of Huntington’s Disease
研究自主神经功能障碍作为亨廷顿病的早期病理特征
- 批准号:
10360540 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:
The Association of Autonomic Dysfunction with the Relationship between Depression and Coronary Disease
自主神经功能障碍与抑郁症和冠心病之间的关系
- 批准号:
10524731 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:
Investigating Autonomic Dysfunction as an Early Pathologic Feature of Huntington’s Disease
研究自主神经功能障碍作为亨廷顿病的早期病理特征
- 批准号:
10620644 - 财政年份:2021
- 资助金额:
$ 36.04万 - 项目类别:














{{item.name}}会员




